| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/17/2011 | WO2011031842A1 N-4 ( - ( ( 3- ( 2 -amino-4 pyrimidinyl) -2 -pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer |
| 03/17/2011 | WO2011031833A2 Human anti-cancer antibodies |
| 03/17/2011 | WO2011031676A2 Depleting immunosuppressive monocytes within a mammal |
| 03/17/2011 | WO2011031561A2 Nucleic acid molecules and uses thereof |
| 03/17/2011 | WO2011031503A2 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10) |
| 03/17/2011 | WO2011031474A2 Use of metformin in cancer treatment and prevention |
| 03/17/2011 | WO2011031460A2 Novel anti-inflammatory peptides that bind oxidized phospholipids |
| 03/17/2011 | WO2011031441A1 Therapy with a chimeric molecule and a pro-apoptotic agent |
| 03/17/2011 | WO2011031073A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof |
| 03/17/2011 | WO2011030929A1 Compound for inhibiting type 3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011030927A1 Compound for inhibiting type-3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011030903A1 Composition for alleviating ultraviolet radiation-induced damage |
| 03/17/2011 | WO2011030892A1 Novel substrate peptide for rho-kinase |
| 03/17/2011 | WO2011030855A1 Method for producing medicinal composition |
| 03/17/2011 | WO2011030851A1 Process for production of natural killer cells |
| 03/17/2011 | WO2011030847A1 Inducer composition for hematopoietic stem cells |
| 03/17/2011 | WO2011030841A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4) |
| 03/17/2011 | WO2011030798A1 8-oxodihydropurine derivative |
| 03/17/2011 | WO2011030568A1 Therapeutic agent for small cell lung cancer |
| 03/17/2011 | WO2011030312A1 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| 03/17/2011 | WO2011030106A1 Cancer cell apoptosis |
| 03/17/2011 | WO2011029980A1 Therapeutic compositions for the treatment of hpv-induced diseases |
| 03/17/2011 | WO2011029956A1 Flavones and flavanones derivates as dna methyltransferases inhibitors |
| 03/17/2011 | WO2011029915A1 Ether derivatives of bicyclic heteroaryls |
| 03/17/2011 | WO2011029842A1 Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer |
| 03/17/2011 | WO2011029807A1 Ortho substituted pyrimidine compounds as jak inhibitors |
| 03/17/2011 | WO2011029804A1 Inhibitors of jak |
| 03/17/2011 | WO2011029802A1 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 03/17/2011 | WO2011029782A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
| 03/17/2011 | WO2011029775A1 [1,2,4]TRIAZOLO [1,5-c]PYRIMIDINE DERIVATIVES AS Hsup90 MODULATORS |
| 03/17/2011 | WO2011029696A1 Directed evolution of arginine deiminase for increased activity at physiological ph |
| 03/17/2011 | WO2011029639A2 Compounds and methods for treating neoplasia |
| 03/17/2011 | WO2011029537A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs |
| 03/17/2011 | WO2011029415A1 Cyclobutan-1,1 -dicarboxylato complexes of platinum with n6-benzyladenine derivatives, method of their preparation and application of these complexes as drugs in antitumour therapy |
| 03/17/2011 | WO2011029392A1 Androgen receptor antagonists and uses thereof |
| 03/17/2011 | WO2011029359A1 MEDICAMENTS CONTAINING 11β HYDROXYSTEROID DEHYDROGENASE 1 DOUBLE REGULATORS AND USES THEREOF |
| 03/17/2011 | WO2011029279A1 Fused heteroaryl compounds, preparation method and use thereof |
| 03/17/2011 | WO2011029265A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof |
| 03/17/2011 | WO2011029193A1 Method of treating cancer by inhibiting trim59 expression or activity |
| 03/17/2011 | WO2011006803A8 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
| 03/17/2011 | WO2010141738A3 Compositions and method for inhibiting tumor growth |
| 03/17/2011 | WO2010129789A3 Modified tumor necrosis factor-beta |
| 03/17/2011 | WO2010093789A8 A composition comprising (-) -trans-3- (5, 6-dihydro-4h-pyrrolo [3,2,1-ij] quinolin-1-yl)-4-(1h-indol-3-yl) pyrrolidine- 2, 5-dione in combination with a second anti-proliferative agent |
| 03/17/2011 | WO2010085588A8 Modulating angiogenesis |
| 03/17/2011 | WO2010083414A8 Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| 03/17/2011 | US20110067142 Hybrid artichoke variety nun 4006 ar |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110066230 Fluorinated GHRH Antagonists |
| 03/17/2011 | US20110066101 Non-invasive ocular drug delivery |
| 03/17/2011 | US20110065918 New phenylalanine derivatives |
| 03/17/2011 | US20110065800 Formulations for cathepsin k inhibitors |
| 03/17/2011 | US20110065799 Urokinase inhibitors, production and use thereof |
| 03/17/2011 | US20110065786 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species |
| 03/17/2011 | US20110065779 Aav vector compositions and methods for enhanced expression of immunoglobulins using the same |
| 03/17/2011 | US20110065777 DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENE |
| 03/17/2011 | US20110065773 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110065767 Substituted CC-1065 Analogs and Their Conjugates |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065750 Solid Forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and Methods of Making the Same |
| 03/17/2011 | US20110065748 Compositions and methods for treating disorders of gastrointestinal motility |
| 03/17/2011 | US20110065745 Polysubstituted 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof |
| 03/17/2011 | US20110065736 Quinazoline derivatives as vegf inhibitors |
| 03/17/2011 | US20110065734 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 03/17/2011 | US20110065729 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 03/17/2011 | US20110065727 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065726 Organic Compounds |
| 03/17/2011 | US20110065716 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/17/2011 | US20110065712 Tricyclic compounds and pharmaceutical uses thereof |
| 03/17/2011 | US20110065709 Aurora kinase modulators and method of use |
| 03/17/2011 | US20110065708 Heterocyclic oxime compounds |
| 03/17/2011 | US20110065705 Compositions and Methods of Treating Cell Proliferation Disorders |
| 03/17/2011 | US20110065703 Novel agents of calcium ion channel modulators |
| 03/17/2011 | US20110065702 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 03/17/2011 | US20110065701 Pharmaceutical compounds |
| 03/17/2011 | US20110065700 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065698 Novel protein kinase modulators |
| 03/17/2011 | US20110065690 Compositions and methods for treatment of leukemia |
| 03/17/2011 | US20110065688 Therapeutic piperazines |
| 03/17/2011 | US20110065687 Hydrazide compounds and uses thereof |
| 03/17/2011 | US20110065685 Novel indoles are cannabinoid receptor ligands |
| 03/17/2011 | US20110065684 Phthalazine derivatives as parp inhibitors |
| 03/17/2011 | US20110065681 Amide compounds, compositions and uses thereof |
| 03/17/2011 | US20110065676 Combination therapies comprising par1 antagonists with nar agonists |
| 03/17/2011 | US20110065675 Azo dye related small molecule modulators of protein-protein interactions |
| 03/17/2011 | US20110065672 Bisphosphonate-prostatic acid phosphatase inhibitor conjugates to treat prostate cancer bone metastasis |
| 03/17/2011 | US20110065664 Kinase protein binding inhibitors |
| 03/17/2011 | US20110065663 Anti-cancer combination therapy |
| 03/17/2011 | US20110065659 Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 03/17/2011 | US20110065657 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 03/17/2011 | US20110065650 Methods of Inhibiting Tumor Cell Proliferation |
| 03/17/2011 | US20110065649 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 03/17/2011 | US20110065643 Clusterin Pharmaceuticals and Treatment Methods Using the Same |
| 03/17/2011 | US20110065641 Polypeptide and dna thereof useful as a neovascular marker |
| 03/17/2011 | US20110065640 Anti-invasive and anti-angiogenic compositions |
| 03/17/2011 | US20110065639 Compositions and methods for visualizing and eliminating cancer stem cells |
| 03/17/2011 | US20110065632 Pharmaceutical compositions of somatostatin-dopamine conjugates |
| 03/17/2011 | US20110065630 Use of a octreotide as a therapeutic agent |
| 03/17/2011 | US20110065173 Vector |
| 03/17/2011 | US20110065147 Methods and reagents for modulating cholesterol levels |
| 03/17/2011 | US20110065138 Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation |